Champions OncologyCSBR

13F holders, Q2 2024 (June 30)
23holders −2
0new positions
2sold out
2famous investors
$5.17avg. 13F price*

At the end of Q2 2024, 23 institutions reported holding Champions Oncology Inc. (CSBR) in their 13F filings, down 2 from Q1 2024. 0 opened new positions and 2 sold out. The largest holders were Battery Management Corp. ($12.5M), NEA Management Company, LLC ($8.9M) and Tocqueville Asset Management L.P. ($3.5M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Champions Oncology Inc.
CUSIP
15870P307
Latest filing quarter
Q2 2026

History

Number of 13F holders

010203040 Q1 2024: 25Q1 2024Q2 2024: 23Q2 2024Q3 2024: 22Q3 2024Q4 2024: 25Q4 2024Q1 2025: 34Q1 2025Q2 2025: 30Q2 2025Q3 2025: 27Q3 2025Q4 2025: 27Q4 2025Q1 2026: 25Q1 2026Q2 2026: 28Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions0$0
Exits2$379K

All 13F filers, Q1 2024 → Q2 2024: 226,638 shares bought and 86,091 shares sold, net +140,547 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 23 holders

Battery Management Corp. 3.29% No change 2,421,673 $12.5M
NEA Management Company, LLC 0.67% No change 1,713,720 $8.9M
Tocqueville Asset Management L.P. 0.06% No change 684,628 $3.5M
Vanguard Group Inc. 0.00% Add +258.6% 307,002 $1.6M
Renaissance Technologies 0.00% Reduce -1.7% 122,591 $634K
BlackRock Inc. 0.00% Add +0.3% 116,072 $600K
Goldman Sachs Group Inc. 0.00% Add +0.0% 69,304 $358K
Geode Capital Management, LLC 0.00% Add +1.6% 63,086 $326K
Morgan Stanley 0.00% Add +5.9% 43,100 $223K
Northern Trust Corp. 0.00% Reduce -5.2% 40,463 $209K
HighTower Advisors, LLC 0.00% No change 34,308 $178K
Acadian Asset Management LLC 0.00% No change 30,697 $157K
Bank of New York Mellon Corp 0.00% No change 26,749 $138K
State Street Corp. 0.00% No change 26,553 $137K
Bank of America Corp. 0.00% Reduce -2.1% 25,273 $131K
Cambridge Investment Research Advisors, Inc. 0.00% No change 12,252 $63K
Mesirow Financial Investment Management, Inc. 0.00% Reduce -3.1% 12,000 $62K
Stifel Financial Corp. 0.00% Reduce -2.2% 10,942 $57K
Citadel Advisors 0.00% Reduce -20.3% 10,218 $53K
Simplex Trading, LLC 0.00% Add +88.1% 3,004 $15K
UBS Group AG 0.00% Reduce -65.8% 379 $2K
Royal Bank of Canada 0.00% Add +107.8% 133 $1K
JPMorgan Chase & Co. 0.00% No change 11 $57

"% of holder's portfolio" is CSBR's weight in each manager's 13F, not the share of Champions Oncology Inc. the manager owns.